Pharmacovigilance & Drug Safety: Risk Management & Regulatory Compliance Conference

March 12-13, 2019 | Alexandria, VA
Sheraton Suites Old Town Alexandria
Download Agenda


“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead

About the Conference:

To meet the increasing demands of regulatory authorities, both in the US and abroad, executives work to ensure the detection of potential signals indicating trends in adverse event incidents, to identify, report and remediate safety threats through the use of multi-channel reporting systems, monitoring of online social media, as well as partnering with physicians and patients to collect data. As technology has increased in sophistication and automation takes a greater place in reporting and analysis, drug safety and pharmacovigilance executives are continuously adding new tools to an already robust set of skills, ensuring patient safety remains at the heart of the industry.

Topics to Be Addressed:

  • Risk-Based Approaches to Signal Detection & Surveillance
  • Supporting Clearance through Proactive Safety in Clinical Research
  • Drug Safety Monitoring in the Post-Approval Environment
  • Use of Real-World Data to Support Long-Term Product Safety
  • Transforming Safety from National to Global Safety Surveillance
  • Technology & Automation in the Future of Pharmacovigilance

Program Highlights:

  • Multi-Part Sessions Covering Regulatory Analysis & Integration
  • Small-Group Discussions throughout Focused on Implementation
  • Global Perspectives Ensuring High Level & Strategic Nature of Program


75 Attendees

All attendees come directly from pharmaceutical and biotech companies

Distinguished Presenters

16 Speakers

with an average of 15 years experience


Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices